It can be dangerous to invest retirement-plan funds in esoteric assets without proper guidance. A husband and wife in Rhode Island have learned that lesson the hard way.
Jim Cramer has never been shy to use buzzers and bells to make the occasionally esoteric world of finance more interesting.
The deal is an advance purchase agreement between Novavax and Israel's Ministry of Health. The Novavax jab is not yet authorized or approved for use in Israel; so far, the country has only approved fellow biotech Moderna's mRNA-1273 (Spikevax) and Comirnaty from Pfizer and BioNTech. In its press release on the matter, Novavax wrote that it "will work with the Ministry of Health to obtain the necessary authorizations and finalize plans for distribution in Israel pending regulatory approval."
Microsoft has restored the market’s faith in the cloud, while IBM reminded investors there was still value in a legacy business.
High-dividend stocks can be misleading. Here's a smart way to find stable stocks with high dividends. Watch these eight dividend payers on IBD's radar.
Investors may soon be able to preserve their retirement war chest for longer. The Securing a Strong Retirement Act, a bill originally pushed in 2021 but which may finally pass this year, would push the starting point for required minimum … Continue reading → The post RMDs May Soon Start Even Later for Retirement Plan Savers appeared first on SmartAsset Blog.
To put this question another way: What year’s U.S. retirees had the greatest difficulty sustaining their retirement standard of living, relative to any other year’s retirees of the last two centuries? If you’re like almost everyone else, your first guess is the summer of 1929, just prior to that year’s stock market crash. Close runners up include early 2000, just prior to the bursting of the Internet bubble, 1987 prior to that year’s stock market crash, or October 2007 before the Great Financial Crisis.
One top Wall Street auto analyst thinks this Tesla rival has a massively undervalued stock price. Here's why.
Investing $200,000 in this basket of dividend stocks should earn you $12,800 in passive income in 2022.
It took less than 17 months for the broad-based S&P 500 to double in value. Based on the highest price target issued by Wall Street analysts and investment banks, the following four under-the-radar stocks have the potential to skyrocket between 319% and 645% in 2022. The first stock with significant upside potential, at least according to one analyst, is clinical-stage biotech stock Ocugen (NASDAQ: OCGN).
Nvidia GPUs power self-driving cars and cloud gaming, with the chip giant also expanding fast into the metaverse. Is Nvidia stock a buy?
Announcing a new Fortune 500 customer was all it took for Knightscope to boost its shares well past their public offering price.
Advanced Micro Devices Inc. earnings will serve as an important indicator on whether the semiconductor outlook is truly weak for the March-ending quarter or whether it's just weak for certain companies.
The central bank staved off a downturn that could have been far worse than the quick recession and correction we saw in 2020. But now we’re about to find out just how much the Fed doesn’t know about what its policies have created.
The company committed a record $625 million over 20 years to put its name on Los Angeles' football stadium. It's about to get an early two-for-one payoff as the stadium hosts the NFC Championship Game between the 49ers and Rams, and then Super Bowl LVI.
Shares of Plug Power (NASDAQ: PLUG) are getting hit hard with sell-offs recently. The hydrogen technology company's stock was down roughly 12.4% since last week's market close as of 1:45 p.m. ET Friday, according to data from S&P Global Market Intelligence. There doesn't appear to be any fresh, company-specific news sending the hydrogen technologies specialist's shares lower this week, but it's not surprising to see the stock down double-digits at a time when investors have a mounting collection of risk factors to consider.
The Euro has collapsed during the bulk of the trading week, we continue to see the US dollar favorite against almost every other currency out there. With this major “risk off” trade, I do not see this changing.
The stock market was having a generally strong day on Friday, with all three major averages in the green, led by the tech-heavy Nasdaq. There are a couple of reasons Affirm is such an outperformer today. Analyst Christopher Brendler said in his note that the sell-off in Affirm has greatly improved the risk/reward dynamics of the stock.
The recent market sell-off, primarily driven by growth stocks' dives, has created tremendous opportunities for investors to buy shares of excellent companies at a discount. While the current economic issues may continue to impact the market's performance in the short term, investors focused on the long game had better stay the course. Let's look at two well-known companies that haven't escaped the recent bloodbath: Meta Platforms (NASDAQ: FB) and Amazon (NASDAQ: AMZN).
Robinhood generates the majority of its revenue from payment for order flow, a practice that is undergoing examination from the SEC.
Shares of Visa (NYSE: V) surged 10.6% on Friday after the digital payments giant delivered impressive fiscal 2022 first-quarter earnings results. Visa's revenue jumped 24% year over year to $7.1 billion. Notably, Visa's lucrative cross-border volume -- which is comprised of transactions between purchasers and merchants that reside in different countries -- soared 40%.